Last update:

Vaccination news

Diseases, Conditions, Syndromes

Scientists identify 'unconventional' new pathway for TB vaccines

An "unconventional" immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according ...

Diseases, Conditions, Syndromes

A 'new era' in malaria control has begun with a vaccination campaign for children in Ivory Coast

Health workers in Ivory Coast began giving children the latest malaria vaccine on Monday, the beginning of a regional campaign that experts hope might curb the impact of one of Africa's top killers.

Pediatrics

UN alarmed as childhood immunization levels stall

Global childhood vaccination levels have stalled, leaving millions more children un- or under-vaccinated than before the pandemic, the UN said Monday, warning of dangerous coverage gaps enabling outbreaks of diseases like ...

Diseases, Conditions, Syndromes

COVID still kills 1,700 a week: WHO

COVID-19 is still killing around 1,700 people a week around the world, the World Health Organization said Thursday, as it urged at-risk populations to keep up with their vaccinations against the disease.

Obstetrics & gynaecology

Study backs RSV vaccine safety during pregnancy

Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a study by Weill ...

Vaccination

Scientists discover PVP-037, a potent vaccine adjuvant

Many vaccines are only partially effective, have waning efficacy, or do not work well in the very young or the very old. For more than a decade, Ofer Levy, MD, Ph.D., and David Dowling, Ph.D., in the Precision Vaccines Program ...

Oncology & Cancer

Breast cancer vaccine study begins with first patient

An innovative study of a breast cancer vaccine is officially underway, as University of Pittsburgh Medical Center announced on June 20 that the first participant had received her full course of the vaccine.

Diseases, Conditions, Syndromes

As mpox cases rise, experts urge complete, two-part vaccinations

The number of U.S. mpox cases has more than doubled compared with last year, and the federal Centers for Disease Control and Prevention has been urging clinicians across states to encourage vaccinations for those at risk.

Vaccination

FDA gives nod to RSV vaccine for people in their 50s

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.